跳至主要内容
临床试验/NCT05754814
NCT05754814已完成不适用

SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes

Rigshospitalet, Denmark2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年6月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Super-resolution ultrasound image of normal and malignant human lymph nodes

研究概览

简要总结

The goal of this observational study is to visualize the small vessels in normal and cancerous lymph nodes on the neck with a new ultrasound technique.

The main questions it aims to answer are:

  • Is it possible to visualize the network of the smallest vessels in lymph nodes on the neck?
  • Is it possible to distinguish between healthy and cancerous lymph nodes using different parameters?

The participants will have 1 lymph nodes ultrasound scanned with a standard ultrasound technique and the new technique.

详细描述

Super-resolution ultrasound using erythrocytes (SURE) is a new ultrasound technique for visualizing the very small blood vessels in the body. The technique uses tracking of the blood's red blood cells (erythrocytes) to achieve a higher resolution of the blood vessels' shape, structure, and blood flow. The technique makes it possible to create images with much higher resolution than normal ultrasound, which means that even very small blood vessels can be imaged and measured.

In many diseases, the small blood vessels change their function or structure. One of the major disease groups where SURE has significant potential is cancer. In cancerous nodes, the small blood vessels change: they become twisted, irregular, and function poorly. If changes in the small vessels can be detected at an early stage using SURE, it can lead to quicker diagnoses and better evaluations of the effectiveness of treatment.

In this study, the investigators aim to demonstrate the practical feasibility of SURE imaging in human lymph nodes and investigate the clinical relevance of SURE imaging in the diagnosis of malignant lymph nodes by comparing lymph nodes from healthy participants with lymph nodes from participants with head and neck cancer metastases or lymphoma.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must be 18 years or older, at the time of signing the informed consent
  • Participants who can lie still for 1 minute
  • Capable of giving signed informed consent
  • Inclusion criteria for healthy participants:
  • Participants who are overtly healthy as determined by medical history
  • Participants who have a superficial lymph node laterally on the neck with a normal appearance on standard B-mode ultrasound available for SURE imaging
  • Inclusion criteria for participants with head and neck cancer or lymphoma:
  • Participants who, besides their untreated head and neck cancer or lymphoma, are overtly healthy as determined by medical evaluation and medical history
  • Participants with lymphoma or head and neck cancer and lymph node metastasis verified by a biopsy or surgical excision.
  • Participants who have superficial lymph nodes laterally on the neck

排除标准

  • Pregnancy
  • Physique making ultrasound scanning difficult
  • Ongoing or recent (within the last 4 weeks) infectious disease (bacterial, viral, fungal, or protozoal) which may give rise to reactive lymph nodes
  • Diseases that cause lymphadenopathy: Some chronic infectious diseases (HIV, Tuberculosis, Hepatitis B), Systemic diseases (rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, other rare systemic diseases*), Primary adrenal insufficiency (Addison´s disease), Leukemia, Lymphoma or other cancers (besides the type of cancer the participant is being examined for at the Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet)
  • Drugs that cause lymphadenopathy: Antibiotics (Cephalosporins, Penicillin, Sulfonamides), Antiepileptics (Carbamazepine, Ethosuximide, Lamotrigine, Phenytoin, Primidone), Antihypertensives (Atenolol, Captopril, Hydralazine), Other (Allopurinol, Imatinib)
  • Castleman's disease, Kikuchi's disease, Kawasaki disease, Inflammatory pseudotumor, Amyloidosis, Kimura disease, Rosai-Dorfman disease, IgG4-related disease, Still's disease, dermatomyositis, Churg-Strauss, histiocytosis, chronic granulomatous diseases, Autoimmune lymphoproliferative syndrome, lipid storage diseases.

结局指标

主要结局

Super-resolution ultrasound image of normal and malignant human lymph nodes

时间窗: 1 minute

With super-resolution ultrasound imaging, the investigators will visualize the microvasculature in the lymph nodes.

次要结局

  • Vessel distribution(1 minute)
  • Microvessel density(1 minute)
  • Flow velocity(1 minute)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nathalie Sarup Panduro

Principal Investigator

Rigshospitalet, Denmark

研究点 (2)

Loading locations...

相似试验